Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Consolidation”

782 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 782 results

Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Not applicableLooking for participantsNCT05726045
What this trial is testing

Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation

Who this might be right for
Tobacco Use Disorder
Central Institute of Mental Health, Mannheim 140
Testing effectiveness (Phase 2)Study completedNCT00514475
What this trial is testing

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Oslo University Hospital 160
Not applicableNot Yet RecruitingNCT05184829
What this trial is testing

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

Who this might be right for
ProgressionPostoperative Recovery
Shanghai Zhongshan Hospital 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03709719
What this trial is testing

Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, Adult B-Cell
Assistance Publique - Hôpitaux de Paris 95
Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing

SCION: SABR and Checkpoint Inhibition of NSCLC

Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia
Testing effectiveness (Phase 2)Looking for participantsNCT05464719
What this trial is testing

A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy

Who this might be right for
Large B-cell LymphomaLymphoma
M.D. Anderson Cancer Center 30
Not applicableUnknownNCT06469580
What this trial is testing

Neonatologist-performed Lung Ultrasound (NPLUS) to Guide Respiratory Therapy to Prevent Extubation Failure

Who this might be right for
Neonatal Disease
Medical University of Graz 40
Testing effectiveness (Phase 2)Study completedNCT01652820
What this trial is testing

Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer

Who this might be right for
Non Small-cell Lung Cancer
Spanish Lung Cancer Group 140
Testing effectiveness (Phase 2)Ended earlyNCT04914676
What this trial is testing

Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Acute Myeloid Leukemia
University of Florida 5
Testing effectiveness (Phase 2)Study completedNCT02927262
What this trial is testing

ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation
Astellas Pharma Global Development, Inc. 98
Not applicableUnknownNCT04782089
What this trial is testing

Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Qilu Hospital of Shandong University 20
Large-scale testing (Phase 3)Study completedNCT00003280
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Testing effectiveness (Phase 2)Ended earlyNCT04308785
What this trial is testing

Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell Lung
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783478
What this trial is testing

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

Who this might be right for
Acute Myeloid Leukaemia (AML)
Hospital de Clinicas de Porto Alegre 98
Testing effectiveness (Phase 2)Study completedNCT00778375
What this trial is testing

Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 122
Large-scale testing (Phase 3)Study completedNCT00480064
What this trial is testing

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 360
Testing effectiveness (Phase 2)Ended earlyNCT01222143
What this trial is testing

Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University Health Network, Toronto 12
Not applicableStudy completedNCT06155890
What this trial is testing

Restoring Mobility: Roles of Percutaneous Consolidation for Pelvic Ring Bone Lesions

Who this might be right for
Pelvic Ring Tumor Lesions
Centre Hospitalier Universitaire de Nice 138
Next Page